Clinical Trial: ARV-471 or Anastrozole in ER+, HER2- Localized Breast Cancer
Researchers are conducting a phase 2 trial to test ARV-471 or anastrozole in patients with ER+, HER2- localized breast cancer.
All articles by Cancer Therapy Advisor Contributing Writer
MRI Is Best for Detecting Breast Cancer in Patients With Dense Breasts and Negative Mammography
MRI is the best supplemental imaging modality for detecting breast cancer in women with dense breasts and negative mammography, a meta-analysis suggests.
Docetaxel Acts as Radiosensitizer in Head and Neck Cancer
Adding docetaxel to radiation improves outcomes for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase 2/3 trial suggests.
Researchers Call for More Scrutiny of Oncology Trial Reports Written by Medical Writers
Oncology trial reports written by medical writers are more likely to have surrogate endpoints as the primary endpoint.
Adjuvant ICI Therapy Provides DFS Benefit in Certain Patients With RCC
Certain patients with resected renal cell carcinoma may benefit from adjuvant treatment with immune checkpoint inhibitors, a meta-analysis suggests.
Ganitumab Provides No Benefit in Metastatic Ewing Sarcoma
Adding ganitumab to standard chemotherapy does not provide a benefit for patients with metastatic Ewing sarcoma, a phase 3 trial suggests.
AYAs With Hematologic Malignancies Have Higher Risk of Early Death
The risk of early death in AYAs with cancer depends on the type of malignancy they have as well as multiple demographic factors, a study suggests.
NSAIDs May Improve the Efficacy of ICIs in Non-Small Cell Lung Cancer
NSAIDs may improve the efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer, a study suggests.
“One-Stop Shop” Screening Centers May Improve Cancer Detection
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...